Land: Malta
Sprog: engelsk
Kilde: Medicines Authority
ISOTRETINOIN
Ennogen Healthcare Ltd Unit G4 Riverside, Industrial Estate, Riverside Way, DA15BSUI, Dartford, Kent , United Kingdom
D10BA01
ISOTRETINOIN 20 mg
SOFT CAPSULE
ISOTRETINOIN 20 mg
POM
ANTI-ACNE PREPARATIONS
Licence number in the source country: United Kingdom - PL40739/0001
Invalid
2018-10-03
1. WHAT ISOTRETINOIN 20 MG IS AND WHAT IT IS USED FOR Isotretinoin 20 mg soft capsules contains the active ingredient isotretinoin. This is a vitamin A derivative, belonging to the retinoid class of medicines. Isotretinoin 20 mg is used to treat severe forms of acne (such as nodular or conglobate acne, or acne at risk of permanent scarring) which has not got better after other anti-acne treatments, including oral antibiotics. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ISOTRETINOIN 20 MG ISOTRETINOIN SHOULD ONLY BE PRESCRIBED BY OR UNDER THE SUPERVISION OF A DERMATOLOGIST (a doctor specialised in the treatment of skin problems) with understanding of the risks of isotretinoin therapy and monitoring requirements. YOUR DOCTOR WILL INFORM YOU ABOUT THE PRECAUTIONS YOU HAVE TO FULFIL WHEN YOU TAKE ISOTRETINOIN 20 MG. Additionally, you should receive information materials from your doctor. If not, ask your doctor for this information. If your doctor has not explained the precautionary measures or you have not understood them, please contact your doctor before you start taking Isotretinoin 20 mg. DO NOT TAKE ISOTRETINOIN 20 MG ! IF YOU ARE PREGNANT or think you may be pregnant ! IF YOU ARE BREAST-FEEDING ! IF YOU ARE ABLE TO BECOME PREGNANT BUT ARE UNABLE OR UNWILLING TO FOLLOW THE NECESSARY PREGNANCY PREVENTION MEASURES THAT ARE LISTED IN THE PREGNANCY PREVENTION PROGRAMME ISOTRETINOIN 20 MG SOFT CAPSULES Isotretinoin PACKAGE LEAFLET: INFORMATION FOR THE USER THIS MEDICINAL PRODUCT IS STRONGLY TERATOGENIC Please see the brochures on the contraceptive programme and the information you are given in this patient leaflet in section 2 under the heading "Pregnancy Prevention Programme". READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. ! Keep this leaflet. You may need to read it again. ! If you have any further questions, ask your doctor or pharmacist. ! This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even i Læs hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Isotretinoin 20 mg soft capsules Reticutan 20mg soft capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 20 mg isotretinoin. Excipients with known effect Soya-bean oil 265.600 mg Soya-bean oil, partly hydrogenated 15.400 mg Sorbitol solution 70% (non crystallizing) 16.985 mg Ponceau 4R 0.336 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Soft gelatin capsules. Isotretinoin capsules are maroon coloured soft gelatin capsules with the markings Iso20. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Isotretinoin should only be prescribed by or under the supervision of physicians with expertise in the use of systemic retinoids for the treatment of severe acne and a full understanding of the risks of isotretinoin therapy and monitoring requirements. The capsules should be taken with food once or twice daily. _Adults including adolescents and the elderly:_ Isotretinoin therapy should be started at a dose of 0.5 mg/kg daily. The therapeutic response to isotretinoin and some of the adverse effects are dose-related and vary between patients. This necessitates individual dosage adjustment during therapy. For most patients, the dose ranges from 0.5-1.0 mg/kg per day. Long-term remission and relapse rates are more closely related to the total dose administered than to either duration of treatment or daily dose. It has been shown that no substantial additional benefit is to be expected beyond a cumulative treatment dose of 120-150 mg/kg. The duration of treatment will depend on the individual daily dose. A treatment course of 16-24 weeks is normally sufficient to achieve remission. In the majority of patients, complete clearing of the acne is obtained with a single tr Læs hele dokumentet